Patent details

EP2310411 Title: Recombinant fibrinogen

Basic Information

Publication number:
EP2310411
PCT Application Number:
EP2009058754
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097939573
PCT Publication Number:
WO2010004004
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Recombinant fibrinogen
French Title of Invention:
Fibrinogène recombinant
German Title of Invention:
Rekombinantes Fibrinogen
SPC Number:

Dates

Filing date:
09/07/2009
Grant date:
11/05/2016
EP Publication Date:
20/04/2011
PCT Publication Date:
14/01/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/04/2011
EP B1 Publication Date:
11/05/2016
EP B2 Publication Date:
20/03/2019
EP B3 Publication Date:
Lapsed date:
09/07/2016
Expiration date:
09/07/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2019
 
 

Name:
ProFibrix BV
Address:
Zernikedreef 9, 2333 CK Leiden, Netherlands (NL)

Inventor

1

Name:
KOOPMAN, Jacob
Address:
Netherlands (NL)

2

Name:
BOUT, Abraham
Address:
Netherlands (NL)

3

Name:
GRIMBERGEN, Joseph
Address:
Netherlands (NL)

Priority

Priority Number:
08159999
Priority Date:
09/07/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07K 14/75;

Publication

European Patent Bulletin

1

Issue number:
201712
Publication date:
22/03/2017
Description:
Opposition procedure started

2

Issue number:
201912
Publication date:
20/03/2019
Description:
Patent maintained (B2 publication)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages